ABBV
ABBV
NYSE · Biotechnology

Abbvie Inc

S&P 500 Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$201.55
-1.16 (-0.57%)
As of May 9, 9:30 PM ET ·
Analyst Consensus
Strong Buy
40
Analysts
Very High
Coverage
Buy 30 75%
Hold 10 25%
Sell 0 0%
Price Target
Analyst Price Target +27.8% upside
Low Target $173.19
Average Target $257.58
High Target $337.66
Current Price $201.55
Current
$201.55
Target
$257.58
$173.19 $257.58 avg $337.66
Scenario Analysis
Bear Case
$173.19
-14.1%
Low target
Base Case
$257.58
+27.8%
Avg target
Bull Case
$337.66
+67.5%
High target
Risk/Reward
4.8x
Highly favorable
Price in Context
52-Week High
$244.81
-17.7% from high
52-Week Low
$176.57
+14.1% from low
50-Day SMA
$223.82
-9.9% vs SMA
200-Day SMA
$211.12
-4.5% vs SMA
RSI (14)
54.5
Neutral
Target vs 52W High
$257.58
+5.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%